 sucralf versu cimetidin treatment reflux esophag special refer esophag motor function patient double-blind clinic trial effect sucralf granul time mg twenty-six patient sucralf cimetidin short-term pH monitor week treatment thirti patient cimetidin sucralf motil radionuclid test week treatment efficaci treatment symptom endoscop respons week treatment endpoint rate group symptom half patient group differ signific effect treatment pH number spike differ pharmacodynam profil drug mean transit time mtt treatment residu activ radionuclid transit posit treatment cimetidin data support hypothesi primari dysmotil pathogenesi reflux esophag patient possibl combin therapi sucralf cimetidin